Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABSINASDAQ:ADVNASDAQ:AUGXNASDAQ:RPAY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSIAbsci$2.79+1.5%$2.90$2.01▼$6.33$350.79M2.062.84 million shs9.77 million shsADVAdvantage Solutions$1.63+3.2%$1.31$1.04▼$4.16$512.41M2.02635,671 shs1.99 million shsAUGXAugmedix$2.35$2.34$0.73▼$6.25$115.08M-0.22635,746 shsN/ARPAYRepay$4.63+0.7%$4.43$3.59▼$10.86$457.42M1.61.13 million shs1.72 million shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSIAbsci+1.45%+0.36%+3.33%-7.31%-19.83%ADVAdvantage Solutions+3.16%+13.19%+39.32%-7.39%-44.93%AUGXAugmedix0.00%0.00%0.00%0.00%+213.33%RPAYRepay+0.65%-3.14%+7.42%-19.34%-56.89%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABSIAbsci2.0336 of 5 stars3.51.00.00.02.21.70.6ADVAdvantage Solutions2.6768 of 5 stars3.51.00.00.02.32.51.3AUGXAugmedixN/AN/AN/AN/AN/AN/AN/AN/ARPAYRepay3.9146 of 5 stars4.34.00.00.00.64.21.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSIAbsci 3.00Buy$8.40201.08% UpsideADVAdvantage Solutions 3.00Buy$2.2538.04% UpsideAUGXAugmedix 2.00Hold$2.35N/ARPAYRepay 2.56Moderate Buy$7.9070.63% UpsideCurrent Analyst Ratings BreakdownLatest AUGX, RPAY, ADV, and ABSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025RPAYRepayCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$8.00 ➝ $4.505/14/2025RPAYRepayMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$4.505/14/2025ADVAdvantage SolutionsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$2.005/14/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.005/13/2025ADVAdvantage SolutionsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$3.50 ➝ $2.505/13/2025RPAYRepayBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$7.00 ➝ $5.005/13/2025RPAYRepayKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$6.50 ➝ $4.505/13/2025RPAYRepayUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$7.50 ➝ $4.504/16/2025ABSIAbsciKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$5.00 ➝ $9.004/14/2025RPAYRepayBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$9.00 ➝ $6.004/9/2025ABSIAbsciNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSIAbsci$4.53M78.56N/AN/A$1.56 per share1.79ADVAdvantage Solutions$3.57B0.15$0.34 per share4.74$2.33 per share0.70AUGXAugmedix$51.58M2.23N/AN/A$0.56 per share4.20RPAYRepay$313.04M1.47$2.00 per share2.32$8.76 per share0.53Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSIAbsci-$103.11M-$0.92N/AN/AN/A-2,232.13%-53.69%-45.89%8/13/2025 (Estimated)ADVAdvantage Solutions-$326.96M-$1.16N/AN/AN/A-10.71%-33.99%-8.76%8/6/2025 (Estimated)AUGXAugmedix-$19.17M-$0.43N/A∞N/A-46.23%-182.36%-43.21%N/ARPAYRepay-$10.16M-$0.15N/A6.01N/A-4.16%8.49%4.31%8/14/2025 (Estimated)Latest AUGX, RPAY, ADV, and ABSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025ABSIAbsci-$0.23-$0.21+$0.02-$0.21$1.07 million$1.18 million5/12/2025Q1 2025RPAYRepay$0.23$0.22-$0.01-$0.09$76.06 million$77.33 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSIAbsciN/AN/AN/AN/AN/AADVAdvantage SolutionsN/AN/AN/AN/AN/AAUGXAugmedixN/AN/AN/AN/AN/ARPAYRepayN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABSIAbsciN/A5.725.72ADVAdvantage Solutions2.391.991.99AUGXAugmedix1.481.661.66RPAYRepay0.653.713.71Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSIAbsci52.05%ADVAdvantage Solutions49.82%AUGXAugmedix87.11%RPAYRepay82.73%Insider OwnershipCompanyInsider OwnershipABSIAbsci10.49%ADVAdvantage Solutions6.20%AUGXAugmedix10.97%RPAYRepay12.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSIAbsci210127.56 million114.18 millionOptionableADVAdvantage Solutions69,000324.31 million304.21 millionOptionableAUGXAugmedix1,43048.97 million43.60 millionOptionableRPAYRepay58099.44 million87.51 millionOptionableAUGX, RPAY, ADV, and ABSI HeadlinesRecent News About These CompaniesREPAY Enhances MeridianLink Integration, Modernizing New Member Onboarding and Digital Payment OptionsJune 10, 2025 | finance.yahoo.comRepay Holdings Co. (NASDAQ:RPAY) Shares Sold by Bank of America Corp DEJune 8, 2025 | marketbeat.comRepay Holdings Co. (NASDAQ:RPAY) Given Average Recommendation of "Moderate Buy" by BrokeragesJune 8, 2025 | marketbeat.comRepay (NASDAQ:RPAY) Stock Price Up 5.5% - Time to Buy?June 5, 2025 | marketbeat.comTwo Sigma Investments LP Purchases 60,453 Shares of Repay Holdings Co. (NASDAQ:RPAY)June 4, 2025 | marketbeat.comRepay Holdings Co. (NASDAQ:RPAY) Sees Large Decline in Short InterestJune 3, 2025 | marketbeat.comWellington Management Group LLP Increases Stock Position in Repay Holdings Co. (NASDAQ:RPAY)June 1, 2025 | marketbeat.comVident Advisory LLC Sells 156,907 Shares of Repay Holdings Co. (NASDAQ:RPAY)June 1, 2025 | marketbeat.comSquarepoint Ops LLC Increases Holdings in Repay Holdings Co. (NASDAQ:RPAY)May 30, 2025 | marketbeat.comRepay Holdings’ SWOT analysis: fintech stock faces challenges amid growthMay 27, 2025 | investing.comRepay Holdings Co. (NASDAQ:RPAY) Shares Acquired by Millennium Management LLCMay 26, 2025 | marketbeat.comRepay (NASDAQ:RPAY) Lowered to "Hold" Rating by Wall Street ZenMay 24, 2025 | marketbeat.comSovereign s Capital Management LLC Purchases Shares of 577,760 Repay Holdings Co. (NASDAQ:RPAY)May 21, 2025 | marketbeat.comBNP Paribas Financial Markets Buys New Shares in Repay Holdings Co. (NASDAQ:RPAY)May 21, 2025 | marketbeat.comInsider Buying: Repay Holdings Co. (NASDAQ:RPAY) President Acquires 15,378 Shares of StockMay 17, 2025 | insidertrades.comEarnings Release: Here's Why Analysts Cut Their Repay Holdings Corporation (NASDAQ:RPAY) Price Target To US$7.59May 16, 2025 | finance.yahoo.comWhy Repay Holdings Corporation’s (RPAY) Stock Is Down 6.68%May 16, 2025 | aaii.comRepay ups size of stock buybacks program to up to $75M from $50MMay 13, 2025 | msn.comRepay Holdings Corp (RPAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...May 13, 2025 | uk.finance.yahoo.comREPAY HOLDINGS Earnings Preview: Recent $RPAY Insider Trading, Hedge Fund Activity, and MoreMay 12, 2025 | nasdaq.comRepay Holdings Corporation (RPAY) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Stocks Getting Rare Double Upgrades From AnalystsBy Chris Markoch | June 6, 2025View 3 Stocks Getting Rare Double Upgrades From AnalystsWhy Quantum Computing Inc. Is the Quiet Winner in Quantum StocksBy Jeffrey Neal Johnson | June 18, 2025View Why Quantum Computing Inc. Is the Quiet Winner in Quantum StocksArcher's Midnight Air Taxi Soars, But Stock Doesn’t BudgeBy Jeffrey Neal Johnson | June 4, 2025View Archer's Midnight Air Taxi Soars, But Stock Doesn’t BudgeAMD Accelerates Stack Development: Share Price to FollowBy Thomas Hughes | June 16, 2025View AMD Accelerates Stack Development: Share Price to Follow3 Growth Stocks Too Small for Institutions to BuyBy Gabriel Osorio-Mazilli | June 19, 2025View 3 Growth Stocks Too Small for Institutions to BuyAUGX, RPAY, ADV, and ABSI Company DescriptionsAbsci NASDAQ:ABSI$2.79 +0.04 (+1.45%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.78 -0.01 (-0.36%) As of 06/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.Advantage Solutions NASDAQ:ADV$1.63 +0.05 (+3.16%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.62 0.00 (-0.31%) As of 06/20/2025 04:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Advantage Solutions Inc. provides business solutions to consumer goods manufacturers and retailers in North America and internationally. It operates in two segments, Sales and Marketing. The Sales segment offers brand-centric services, such as headquarter relationship management; analytics, insights, and intelligence; and brand-centric merchandising services. This segment also provides retailer-centric services comprising retailer-centric merchandising and in-store media services. The Marketing segment offers brand-centric services, including shopper and consumer marketing, and brand experiential services; retailer-centric services, such as retail experiential and private label services; and digital marketing, and digital media and advertising services. The company was formerly known as Karman Holding Corp. and changed its name to Advantage Solutions Inc. in March 2016. The company was founded in 1987 and is headquartered in Irvine, California.Augmedix NASDAQ:AUGXAugmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.Repay NASDAQ:RPAY$4.63 +0.03 (+0.65%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$4.64 +0.00 (+0.11%) As of 06/20/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Repay Holdings Corporation, payments technology company, provides integrated payment processing solutions to industry-oriented markets in the United States. It operates through two segments: Consumer Payments and Business Payments. The company's payment processing solutions enable consumers and businesses to make payments using electronic payment methods. It also offers a range of solutions relating to electronic payment methods, including credit and debit card processing, automated clearing house (ACH) processing, e-cash, and digital wallet services; virtual credit card processing, enhanced ACH processing, instant funding, clearing and settlement, and communication solutions; and proprietary payment channels that include Web-based, virtual terminal, online client portal, mobile application, text-to-pay, interactive voice response, and point of sale services. It serves customers primarily operating in the personal loans, automotive loans, receivables management, and business-to-business verticals through direct sales representatives and software integration partners. The company was founded in 2006 and is headquartered in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
